iHuman Inc. (IH)
| Market Cap | 67.47M -53.2% |
| Revenue (ttm) | 112.95M -13.2% |
| Net Income | 10.64M -28.6% |
| EPS | 0.20 -26.3% |
| Shares Out | 51.11M |
| PE Ratio | 6.79 |
| Forward PE | n/a |
| Dividend | $0.10 (7.58%) |
| Ex-Dividend Date | Apr 17, 2026 |
| Volume | 1,560 |
| Open | 1.317 |
| Previous Close | 1.380 |
| Day's Range | 1.317 - 1.317 |
| 52-Week Range | 1.280 - 3.164 |
| Beta | 0.14 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Sep 17, 2026 |
About IH
iHuman Inc., together with its subsidiaries, provides an integrated suite of tech-powered intellectual development products to individual users, kindergartens, and distributors in the People's Republic of China. The company offers interactive and self-directed apps, including iHuman Chinese, iHuman English, iHuman Pinyin, iHuman Math, iHuman Books, iHuman Stories, iHuman Chinese Classics, iHumanpedia, iHuman Kids Workout, iHuman Coding, iHuman Fun Idioms, iHuman Little Artists, iHuman Readers, iHuman Writing, iHuman Fantastic Friends, iHuman AI... [Read more]
Financial Performance
In 2025, iHuman's revenue was 807.02 million, a decrease of -12.49% compared to the previous year's 922.20 million. Earnings were 95.40 million, a decrease of -3.23%.
Financial numbers in CNY Financial StatementsNews
iHuman Inc. Announces First Quarter 2026 Unaudited Financial Results
BEIJING, June 29, 2026 /PRNewswire/ -- iHuman Inc. (NYSE: IH) ("iHuman" or the "Company"), a leading provider of tech-powered knowledge and personal growth products, today announced its unaudited fina...
iHuman Earnings release: Q1 2026
iHuman released its Q1 2026 earnings on June 29, 2026, summarizing the period's financial results.
Jazz Pharmaceuticals Delivers Extensive Late-Breaking Data at SLEEP 2026, Demonstrating Real-World Impact of Xywav® (calcium, magnesium, potassium, and sodium oxybates) on Patient Outcomes Across Narcolepsy and Idiopathic Hypersomnia
New late-breaking data presentations underscore Jazz's significant progress in advancing holistic understanding of narcolepsy and idiopathic hypersomnia, including novel real-world evidence of meaning...
iHuman acquires businesses related to All Knowledge, Perfect Lingo for RMB 94M
iHuman (IH) announced that it has entered into certain asset transfer agreements to acquire the businesses and assets related to two products, All Knowledge and Perfect Lingo, for an aggregate…
iHuman Inc. Announces Acquisition of Businesses and Assets Related to All Knowledge and Perfect Lingo
BEIJING, May 31, 2026 /PRNewswire/ -- iHuman Inc. (NYSE: IH) ("iHuman" or the "Company"), a leading provider of tech-powered, intellectual development products in China, today announced that it has en...
iHuman Inc. Files 2025 Annual Report on Form 20-F
BEIJING, April 24, 2026 /PRNewswire/ -- iHuman Inc. (NYSE: IH) ("iHuman" or the "Company"), a leading provider of tech-powered, intellectual development products in China, today announced that it file...
iHuman Earnings release: Q4 2025
iHuman released its Q4 2025 earnings on March 31, 2026, summarizing the period's financial results.
iHuman Inc. Announces Fourth Quarter and Fiscal Year 2025 Unaudited Financial Results
BEIJING, March 31, 2026 /PRNewswire/ -- iHuman Inc. (NYSE: IH) ("iHuman" or the "Company"), a leading provider of tech-powered, intellectual development products in China, today announced its unaudite...
iHuman Earnings release: Q3 2025
iHuman released its Q3 2025 earnings on December 29, 2025, summarizing the period's financial results.
iHuman Inc. Announces Third Quarter 2025 Unaudited Financial Results
BEIJING , Dec. 29, 2025 /PRNewswire/ -- iHuman Inc. (NYSE: IH) ("iHuman" or the "Company"), a leading provider of tech-powered, intellectual development products in China, today announced its unaudite...
iHuman to Present at Noble Capital Markets' 21st Annual Emerging Growth Equity Conference
Beijing, China--(Newsfile Corp. - November 24, 2025) - iHuman Inc. (NYSE: IH), a leading provider of tech-powered, intellectual development products in China, today announced that its Investor Relatio...
iHuman Earnings release: Q2 2025
iHuman released its Q2 2025 earnings on September 18, 2025, summarizing the period's financial results.
iHuman Inc. Announces Second Quarter 2025 Unaudited Financial Results
BEIJING , Sept. 18, 2025 /PRNewswire/ -- iHuman Inc. (NYSE: IH) ("iHuman" or the "Company"), a leading provider of tech-powered, intellectual development products in China, today announced its unaudit...
iHuman and Cricket Media Team Up to Launch Reading Stars
Reading Stars seamlessly merges Cricket's award-winning content with iHuman's cutting-edge technology, creating an entirely new way for children to engage with reading. BEIJING and MCLEAN, Va.
iHuman Earnings release: Q1 2025
iHuman released its Q1 2025 earnings on June 26, 2025, summarizing the period's financial results.
iHuman Inc. Announces First Quarter 2025 Unaudited Financial Results
BEIJING , June 26, 2025 /PRNewswire/ -- iHuman Inc. (NYSE: IH) ("iHuman" or the "Company"), a leading provider of tech-powered, intellectual development products in China, today announced its unaudite...
iHuman Inc. Files 2024 Annual Report on Form 20-F
BEIJING , April 28, 2025 /PRNewswire/ -- iHuman Inc. (NYSE: IH) ("iHuman" or the "Company"), a leading provider of tech-powered, intellectual development products in China, today announced that it fil...
iHuman Earnings release: Q4 2024
iHuman released its Q4 2024 earnings on March 25, 2025, summarizing the period's financial results.
iHuman Inc. Announces Fourth Quarter and Fiscal Year 2024 Unaudited Financial Results
BEIJING , March 25, 2025 /PRNewswire/ -- iHuman Inc. (NYSE: IH) ("iHuman" or the "Company"), a leading provider of tech-powered, intellectual development products in China, today announced its unaudit...
iHuman Earnings release: Q3 2024
iHuman released its Q3 2024 earnings on December 26, 2024, summarizing the period's financial results.
iHuman Inc. Announces Third Quarter 2024 Unaudited Financial Results
BEIJING , Dec. 26, 2024 /PRNewswire/ -- iHuman Inc. (NYSE: IH) ("iHuman" or the "Company"), a leading provider of tech-powered, intellectual development products in China, today announced its unaudite...
iHuman Earnings release: Q2 2024
iHuman released its Q2 2024 earnings on September 27, 2024, summarizing the period's financial results.
iHuman reports Q2 revenue RMB215.1M vs. RMB241M last year
Reports Q2 net income RMB24.7M vs. RMB42.1M last year. Average total MAUs for the second quarter were 24.57M, a year-over-year increase of 20.8%. Dr. Peng Dai, Director and CEO of…
iHuman Inc. Announces Second Quarter 2024 Unaudited Financial Results
BEIJING , Sept. 27, 2024 /PRNewswire/ -- iHuman Inc. (NYSE: IH) ("iHuman" or the "Company"), a leading provider of tech-powered, intellectual development products in China, today announced its unaudit...
iHuman Earnings release: Q1 2024
iHuman released its Q1 2024 earnings on June 28, 2024, summarizing the period's financial results.